Maryland Capital Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$203 Buy
+3
New +$200 ﹤0.01% 444
2023
Q4
Sell
-54
Closed -$5.04K 239
2023
Q3
$5.04K Sell
54
-6
-10% -$676 ﹤0.01% 185
2023
Q2
$7.71K Buy
+60
New +$7.26K 0.01% 183

Other funds holding DXCM

Maryland Capital Advisors's DXCM Position: Q2 2026 in Review

Maryland Capital Advisors opened a new position in DexCom (DXCM) in Q2 2026: 3 shares worth $203. The stake represents ﹤0.01% of the portfolio and ranks #444 among its holdings. This is a return to the name: Maryland Capital Advisors previously reported a position in DXCM as recently as Q3 2023.

Maryland Capital Advisors first reported a position in DXCM in Q2 2023 and has held it in 3 quarters since. The position peaked at $7.71K in Q2 2023. 115 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Maryland Capital Advisors held 3 shares of DexCom worth $203 as of Q2 2026.
  • DexCom was a new Maryland Capital Advisors position in Q2 2026.
  • DexCom made up ﹤0.01% of Maryland Capital Advisors's portfolio in Q2 2026, its #444 holding.
  • Maryland Capital Advisors first reported a position in DexCom in Q2 2023 and has held it in 3 quarters since.
  • Maryland Capital Advisors's DexCom position peaked at $7.71K in Q2 2023.
  • 115 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Maryland Capital Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.